Anatara Ga News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Anatara ga. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Anatara Ga Today - Breaking & Trending Today
ASX Health Stocks: AVITA flies as high as 24pc after providing big, bullish guidance heraldsun.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heraldsun.com.au Daily Mail and Mail on Sunday newspapers.
Microba Life Sciences will work with Anatara Life Sciences (ASX:ANR) to complete microbiome analysis for a therapeutic treatment for sufferers of. ....
Monthly Activities ReportMelbourne, July 28, 2021 AEST (ABN Newswire) - Anatara Lifesciences Limited ( ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in animals and humans, is pleased to provide this activities report for the quarter ending 30 June 2021 (Q4 FY21), along with the Company s Appendix 4C cash flow report. Commenting on the quarter, CEO Steve Lydeamore said, Anatara is pleased to have made solid progress in obtaining the appropriate approval and grants for our human and animal health products over this period. We are at an exciting phase of Anatara s development, with two human clinical trials now imminent, and a number of pathways being pursued for the commercialisation of both the human and animal products. ....
Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals is pleased to provide this update on clinical trial activities. ....
Q3 FY21 Activities ReportMelbourne, April 27, 2021 AEST (ABN Newswire) - Anatara Lifesciences ( ASX:ANR), a developer of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans, is pleased to provide this activities report for the quarter ending 31 March 2021, along with the Company s Appendix 4C cash flow report. Commenting on the quarter, CEO Steve Lydeamore said, Anatara is pleased to have successfully progressed two key milestones during the period - a successful trial for Anatara s proprietary enriched formulation for poultry in water, and ethics approval to start the human IBS trial. Anatara now has approval to commence two separate human trials for its Gastrointestinal Re-Programming complementary medicine (GaRP), and there appears to be a wider appreciation of the Company s human health initiatives and the potential to improve overall human wellbeing with ....